Product Description: IL17A-IN-1 (compound 72) is an orally active Interleukin 17A inhibitor. IL17A-IN-1 can be used in the study of inflammatory and autoimmune diseases (plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis, etc.), as well as cancer[1].
Applications: COVID-19-immunoregulation
Formula: C30H35Cl2N7O3
References: [1]Ramos AL, et al. Discovery of Small Molecule Interleukin 17A Inhibitors with Novel Binding Mode and Stoichiometry: Optimization of DNA-Encoded Chemical Library Hits to In Vivo Active Compounds. J Med Chem. 2024 Apr 4.
Molecular Weight: 612.55
Research Area: Cancer; Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Interleukin Related